West to Participate in Upcoming Investor Conference
West Pharmaceutical Services (NYSE: WST) will present at the Jefferies Global Healthcare Conference in London on November 18, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
West Pharmaceutical Services (NYSE: WST) will present at the Jefferies Global Healthcare Conference in London on November 18, 2026. The presentation is scheduled for 8:00 a.m. GMT. A live audio webcast will be available through the Investors section of the company website, with a replay available for approximately 90 days after the event.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live audio webcast of the event will be available in the "Investors" section of the Company's website at www.westpharma.com. Replay of the webcasts will be available for approximately 90 days after the event.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 26 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year. Headquartered in Exton, Pennsylvania, West in its fiscal year 2025 generated
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-participate-in-upcoming-investor-conference-302928095.html
SOURCE West Pharmaceutical Services, Inc.